{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:54Z","timestamp":1792025214869,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2024zd029"],"award-info":[{"award-number":["2024zd029"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["25MSZX539"],"award-info":[{"award-number":["25MSZX539"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11302-026-10192-0","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:52Z","timestamp":1792022872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting P2Y14R inhibits proliferation of cervical cancer cells and organoids and activates cAMP\/PKA\/CREB signaling pathway"],"prefix":"10.1007","volume":"22","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"10192_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","volume":"21","author":"NR Abu-Rustum","year":"2023","unstructured":"Abu-Rustum NR, Yashar CM, Arend R et al (2023) NCCN guidelines(R) insights: cervical cancer, version 1.2024. J Natl Compr Canc Netw 21:1224\u20131233. https:\/\/doi.org\/10.6004\/jnccn.2023.0062","journal-title":"J Natl Compr Canc Netw"},{"key":"10192_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070115","volume":"379","author":"L Rahangdale","year":"2022","unstructured":"Rahangdale L, Mungo C, O\u2019Connor S et al (2022) Human papillomavirus vaccination and cervical cancer risk. BMJ 379:e070115. https:\/\/doi.org\/10.1136\/bmj-2022-070115","journal-title":"BMJ"},{"key":"10192_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178463","volume":"26","author":"L Boldeanu","year":"2025","unstructured":"Boldeanu L, Assani M-Z, Boldeanu MV et al (2025) Cervical cancer in the era of HPV: translating molecular mechanisms into preventive public health action. Int J Mol Sci 26:8463. https:\/\/doi.org\/10.3390\/ijms26178463","journal-title":"Int J Mol Sci"},{"key":"10192_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P et al (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"key":"10192_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S et al (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"10192_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36:293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206","journal-title":"Oncogene"},{"key":"10192_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188732","volume":"1877","author":"MG Khalafalla","year":"2022","unstructured":"Khalafalla MG, Tran HN, Khalafalla FG (2022) P2Y purinergic signaling in prostate cancer: emerging insights into pathophysiology and therapy. Biochim Biophys Acta Rev Cancer 1877:188732. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188732","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10192_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133165","volume":"10","author":"W-H Li","year":"2015","unstructured":"Li W-H, Qiu Y, Zhang H-Q et al (2015) P2Y2 receptor and EGFR cooperate to promote prostate cancer cell invasion via ERK1\/2 pathway. PLoS ONE 10:e0133165. https:\/\/doi.org\/10.1371\/journal.pone.0133165","journal-title":"PLoS ONE"},{"key":"10192_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/carcin\/bgt493","volume":"35","author":"S Chadet","year":"2014","unstructured":"Chadet S, Jelassi B, Wannous R et al (2014) The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1\/2 signalling pathway. Carcinogenesis 35:1238\u20131247. https:\/\/doi.org\/10.1093\/carcin\/bgt493","journal-title":"Carcinogenesis"},{"key":"10192_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1756-9966-33-53","volume":"33","author":"G Yang","year":"2014","unstructured":"Yang G, Zhang S, Zhang Y et al (2014) The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin. J Exp Clin Cancer Res 33:53. https:\/\/doi.org\/10.1186\/1756-9966-33-53","journal-title":"J Exp Clin Cancer Res"},{"key":"10192_CR11","doi-asserted-by":"publisher","first-page":"G1024","DOI":"10.1152\/ajpgi.00211.2004","volume":"288","author":"R Coutinho-Silva","year":"2005","unstructured":"Coutinho-Silva R, Stahl L, Cheung K-K et al (2005) P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288:G1024-1035. https:\/\/doi.org\/10.1152\/ajpgi.00211.2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10192_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661. https:\/\/doi.org\/10.3389\/fphar.2017.00661","journal-title":"Front Pharmacol"},{"key":"10192_CR13","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1242\/jcs.03490","volume":"120","author":"S Buvinic","year":"2007","unstructured":"Buvinic S, Bravo-Zehnder M, Boyer JL et al (2007) Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells. J Cell Sci 120:4289\u20134301. https:\/\/doi.org\/10.1242\/jcs.03490","journal-title":"J Cell Sci"},{"key":"10192_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/jcp.10242","volume":"195","author":"A Muscella","year":"2003","unstructured":"Muscella A, Elia MG, Greco S et al (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J Cell Physiol 195:234\u2013240. https:\/\/doi.org\/10.1002\/jcp.10242","journal-title":"J Cell Physiol"},{"key":"10192_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-025-10113-7","volume":"22","author":"R da Silva Ebone","year":"2026","unstructured":"da Silva Ebone R, Doleski PH, Jantsch MH et al (2026) P2Y14 receptor activation and neutrophil signaling: linking inflammation to systemic pathophysiology. Purinergic Signal 22:5. https:\/\/doi.org\/10.1007\/s11302-025-10113-7","journal-title":"Purinergic Signal"},{"key":"10192_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-017-2700-9","volume":"137","author":"MA Curet","year":"2018","unstructured":"Curet MA, Watters JJ (2018) P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures. J Neurooncol 137:23\u201331. https:\/\/doi.org\/10.1007\/s11060-017-2700-9","journal-title":"J Neurooncol"},{"key":"10192_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.191.3.423","volume":"191","author":"B Sauter","year":"2000","unstructured":"Sauter B, Albert ML, Francisco L et al (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423\u2013434. https:\/\/doi.org\/10.1084\/jem.191.3.423","journal-title":"J Exp Med"},{"key":"10192_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Liu J et al (2024) cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol 17:5. https:\/\/doi.org\/10.1186\/s13045-024-01524-x","journal-title":"J Hematol Oncol"},{"key":"10192_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00432-025-06212-y","volume":"151","author":"X Liang","year":"2025","unstructured":"Liang X, Xu B, Wang Q et al (2025) RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP\/PKA\/CREB signaling pathway. J Cancer Res Clin Oncol 151:153. https:\/\/doi.org\/10.1007\/s00432-025-06212-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"10192_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46365-x","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Wang H, Han L, et al (2024) Targeting P2Y(14)R protects against necroptosis of intestinal epithelial cells through PKA\/CREB\/RIPK1 axis in ulcerative colitis. Nat Commun 15:2083. https:\/\/doi.org\/10.1038\/s41467-024-46365-x","journal-title":"Nat Commun"},{"key":"10192_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kong Q, Wang J, et al (2020) Complex roles of cAMP-PKA-CREB signaling in cancer. ExpHematol Oncol 9:32. https:\/\/doi.org\/10.1186\/s40164-020-00191-1","journal-title":"Exp Hematol Oncol"},{"key":"10192_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lfs.2011.12.010","volume":"90","author":"EY Moon","year":"2012","unstructured":"Chen TC, Wadsten P, Su S, et al (2002) The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol Ther 1:268\u201376. https:\/\/doi.org\/10.4161\/cbt.80","journal-title":"Life Sci"},{"key":"10192_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.14348\/molcells.2023.2193","volume":"46","author":"MAR Chowdhury","year":"2023","unstructured":"Moon EY, Lee GH, Lee MS, et al (2012) Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1\/Rap1 pathways. Life Sci 90:373\u201380. https:\/\/doi.org\/10.1016\/j.lfs.2011.12.010","journal-title":"Mol Cells"},{"key":"10192_CR24","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258932","volume":"135","author":"N Andr\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Chowdhury MAR, An J, Jeong S (2023) The Pleiotropic Face of CREB Family Transcription Factors. Mol Cells 46:399\u2013413. https:\/\/doi.org\/10.14348\/molcells.2023.2193","journal-title":"J Cell Sci"},{"key":"10192_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258932","volume":"135","author":"N Andr\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Andr\u00e9s-S\u00e1nchez N, Fisher D, Krasinska L (2022) Physiological functions and roles in cancer of the proliferation marker Ki-67. J Cell Sci 135:jcs258932. https:\/\/doi.org\/10.1242\/jcs.258932","journal-title":"J Cell Sci"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10192-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:53Z","timestamp":1792022873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10192"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10192-0","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"30 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval from Chengdu Tianfu Organoid Biobank Co., Ltd.","order":1,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"78"}}